Phosphorylcholine-containing epitope (PC epitope)

Phosphorylcholine (PC) is a small, highly conserved polar head group that serves as a critical epitope recognized by the innate immune system. It is a prominent component of the cell wall of various pathogens, such as Streptococcus pneumoniae, and is also exposed on host cells during apoptosis or when low-density lipoprotein (LDL) undergoes oxidation. These PC-containing epitopes function as both pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), facilitating recognition by C-reactive protein (CRP) and natural antibodies like IgM (e.g., T15/EO6). In clinical research, PC-containing epitopes are primarily targeted for the treatment of atherosclerosis, as their presence on oxidized LDL (oxLDL) drives vascular inflammation and plaque formation. Therapeutic strategies, including PC-based vaccines and monoclonal antibodies like BI-204, aim to enhance the clearance of these epitopes to provide atheroprotection and reduce the risk of cardiovascular events. (Sources: Sjöberg et al., 2022, 'Phosphorylcholine: A Target for Therapeutic Antibodies in Cardiovascular Disease'; Binder et al., 2003, 'The role of natural antibodies in atherogenesis'; Vollmer, 2020, 'Vaccination against atherosclerosis').

Other names

Phosphocholine-containing epitopePC-epitopePhosphorylcholine antigenPC-containing moiety

Binding and neutralization of pro-inflammatory oxidized lipids and pathogens, enhancement of phagocytic clearance of apoptotic cells and debris, and induction of protective immune responses through natural antibody mimicry or stimulation.